Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Quanterix Corp (QTRX)

Quanterix Corp (QTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 650,964
  • Shares Outstanding, K 38,247
  • Annual Sales, $ 122,370 K
  • Annual Income, $ -32,330 K
  • 60-Month Beta 1.41
  • Price/Sales 5.29
  • Price/Cash Flow N/A
  • Price/Book 1.85
Trade QTRX with:

Options Overview Details

View History
  • Implied Volatility 77.59% ( +0.23%)
  • Historical Volatility 55.21%
  • IV Percentile 64%
  • IV Rank 41.14%
  • IV High 111.89% on 04/23/24
  • IV Low 53.62% on 03/22/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 14
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 1,710
  • Open Int (30-Day) 1,534

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.33
  • Number of Estimates 1
  • High Estimate -0.33
  • Low Estimate -0.33
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -106.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.32 +11.10%
on 04/30/24
22.59 -24.66%
on 04/04/24
-4.94 (-22.50%)
since 04/03/24
3-Month
15.32 +11.10%
on 04/30/24
29.70 -42.69%
on 03/08/24
-6.08 (-26.32%)
since 02/02/24
52-Week
15.32 +11.10%
on 04/30/24
29.70 -42.69%
on 03/08/24
+0.62 (+3.78%)
since 05/03/23

Most Recent Stories

More News
Stock Index Futures Move Lower as U.S. Debt Ceiling Uncertainty Weighs on Sentiment, PMI Data in Focus

June S&P 500 futures (ESM23) are down -0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.02% this morning as the U.S. debt ceiling impasse kept risk sentiment fragile, while market participants...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
NKE : 92.15 (-0.28%)
BAER.Z.IX : 51.940 (+2.28%)
MYGN : 19.47 (+1.30%)
LFCR : 6.39 (+0.63%)
MVST : 0.3846 (-4.19%)
GH : 18.88 (+1.61%)
QTRX : 17.02 (+0.59%)
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 55.56% and 11.77%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

QTRX : 17.02 (+0.59%)
XGN : 1.4000 (+1.08%)
Quanterix Corporation (QTRX) Soars 33.7%: Is Further Upside Left in the Stock?

Quanterix Corporation (QTRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

QTRX : 17.02 (+0.59%)
QIPT : 3.95 (-1.50%)
Quanterix’s First Quarter 2023 Earnings Conference Call

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Tuesday, May 9, 2023, to discuss...

QTRX : 17.02 (+0.59%)
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that blood-based NfL measurements provided...

QTRX : 17.02 (+0.59%)
Quanterix to Participate in Barclays Global Healthcare Conference

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays...

QTRX : 17.02 (+0.59%)
Quanterix Corporation (QTRX) Reports Q4 Loss, Misses Revenue Estimates

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 5.66% and 1.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

QTRX : 17.02 (+0.59%)
AYRWF : 2.6600 (+6.40%)
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the fourth quarter and twelve months ended...

QTRX : 17.02 (+0.59%)
PetIQ (PETQ) Reports Q4 Loss, Misses Revenue Estimates

PetIQ (PETQ) delivered earnings and revenue surprises of 37.50% and 4.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

PETQ : 17.04 (+1.19%)
QTRX : 17.02 (+0.59%)
Quanterix to Present at Cowen’s 43rd Annual Health Care Conference

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen’s...

QTRX : 17.02 (+0.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa...

See More

Key Turning Points

3rd Resistance Point 18.57
2nd Resistance Point 18.12
1st Resistance Point 17.57
Last Price 17.02
1st Support Level 16.57
2nd Support Level 16.12
3rd Support Level 15.57

See More

52-Week High 29.70
Fibonacci 61.8% 24.21
Fibonacci 50% 22.51
Fibonacci 38.2% 20.81
Last Price 17.02
52-Week Low 15.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar